Regional Gastrointestinal Permeability Patterns in Juvenile Idiopathic Arthritis: A Window into Subclinical

Francesco La Torre1, Francesca Marasciulo2, Giovanni La Grasta2

  • 1Department of Paediatrics, Pediatric Rheumatology Center, Giovanni XXIII Paediatric Hospital, University of Bari Aldo Moro, 70126 Bari, Italy.

PubMed

Insights

Children with Juvenile Idiopathic Arthritis (JIA) show altered gut permeability in specific segments, even during remission. This suggests subclinical gut dysfunction may contribute to JIA pathogenesis, independent of active disease.

Area of Science:

  • Pediatric Rheumatology
  • Gastroenterology
  • Immunology

Background:

  • Juvenile Idiopathic Arthritis (JIA) is a chronic autoimmune disease affecting children.
  • Gastrointestinal (GI) dysfunction and permeability changes are increasingly implicated in autoimmune conditions.
  • The gut-joint axis is a potential factor in JIA pathogenesis.

Purpose of the Study:

  • To evaluate segment-specific gastrointestinal permeability (GP) in children with JIA.
  • To determine if altered GP in JIA is associated with disease activity.
  • To explore the role of the gut-joint axis in JIA.

Main Methods:

  • Prospective study of 30 children with JIA and 22 healthy controls.
  • Validated multi-sugar absorption test measuring urinary excretion of sucrose, lactulose, mannitol, and sucralose.
  • Assessment of gastric, small intestinal, and colonic permeability; disease activity via JADAS10.

Main Results:

  • Overall small intestinal permeability (LA/MA ratio) was not significantly different between JIA patients and controls.
  • Segment-specific GP alterations were observed in JIA patients, including increased lactulose, mannitol, and sucralose excretion.
  • These GP abnormalities persisted in JIA patients even in clinical remission and showed no significant difference between active disease and remission groups.

Conclusions:

  • Children with JIA exhibit persistent, segmental gastrointestinal permeability alterations.
  • These gut permeability changes occur independently of clinical disease activity, suggesting subclinical mucosal dysfunction.
  • Further research is needed to elucidate the role of the gut-joint axis and intestinal microbiota in JIA pathogenesis.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
912
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
722
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
854
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
609
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
885
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.1K